Advertisement

Biological Trace Element Research

, Volume 79, Issue 1, pp 15–22 | Cite as

Zinc inhibits the mixed lymphocyte culture

  • Cathrin A Campo
  • Nele Wellinghausen
  • Christian Faber
  • Andrea Fischer
  • Lothar Rink
Article

Abstract

The mixed lymphocyte culture (MLC) is an established clinical method for bone marrow transplantation, as it serves as an in vitro model for allogenic reaction and transplantation. We previously showed that cytokine release into the supernatant is a more specific and sensitive parameter for cross-reactivity in the MLC than the common measurement of cell proliferation. Therefore we tried to find an inhibitor of the MLC in vitro with the least side effects in vivo, measuring interferon (IFN)-γ as one of the most important cytokines in posttransplant medicine. Earlier studies showed that zinc is an important trace element for immune function with both stimulatory and inhibitory effects on immune cells. We found that slightly elevated zinc concentrations (three to four times the physiological level), which do not decrease T-cell proliferation in vitro nor produce immunosuppressive effects in vivo, suppress alloreactivity in the mixed lymphocyte culture. In this report we analyzed the mechanism whereby zinc influences the MLC to possibly find a nontoxic way of immunosuppression.

Index Entries

Mixed lymphocyte culture (MLC) mixed lymphocyte reaction (MLR) trace elements zinc 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P. Hayry, L. C. Andersson, S. Nordling, and M. Virolainen, Allograft response in vitro, Transplant Rev. 12, 91–140 (1972).PubMedGoogle Scholar
  2. 2.
    J. Klein and C. L. Chiang, Ability of H-2 regions to induce graft-vs-host disease, J. Immunol. 117, 736–740 (1976).PubMedGoogle Scholar
  3. 3.
    S. G. Danzer and L. Rink, Cytokines in mixed lymphocyte culture as a prospective parameter for transplantation, Med. Klin. 91, 494–500 (1996).Google Scholar
  4. 4.
    I. L. Noronha, M. Eberlein-Gonska, B. Hartley, S. Stephens, J. S. Cameron, and R. Waldherr, In situ expression of tumor necrosis factor-alpha, interferon-gamma and interleukin-2 receptors in renal allograft biopsies, Transplantation 54, 1017–1024 (1992).PubMedCrossRefGoogle Scholar
  5. 5.
    A. M. Dickinson, L. Sviland, P. J. Hamilton, P. Usher, P. Taylor, G. Jackson, et al., Cytokine involvement in predicting clinical-graft-versus-host-disease in allogeneic bone marrow transplant recipients, Bone Marrow Transplant. 13, 65–70 (1994).PubMedGoogle Scholar
  6. 6.
    S. G. Danzer, C. a Campo, and L. Rink, Interferon-gamma plays a key role in the human mixed lymphocyte culture, Bone Marrow Transplant. 18, 991–996 (1996).PubMedGoogle Scholar
  7. 7.
    E. Maraskovsky, W. F. Chen, and K. Shortman, IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cell, J. Immunol. 143, 1210–1214 (1989).PubMedGoogle Scholar
  8. 8.
    G. H. Wong, I. Clark-Lewis, L. McKimm-Breschkin, A. W. Harris, and J. W. Schrader, Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines, J. Immunol. 131, 788–793 (1983).PubMedGoogle Scholar
  9. 9.
    S. G. Danzer, C. a Campo, B. Kunze, H. Kirchner, and L. Rink, Identification of HLA-DRB1 and HLA-DQB1 identical individuals by a cytokine-based mixed lympphocyte culture, Lymphokine Cytokine Res. 13(5), 303–308 (1994).PubMedGoogle Scholar
  10. 10.
    J. Woo, H. F. Sewell, and A. W. Thomson, The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis, Scand. J. Immunol. 31(3), 297–304 (1990).PubMedCrossRefGoogle Scholar
  11. 11.
    B. Ryffel, The carcinogenity of ciclosporin, Toxicology 73(1), 1–22 (1992).PubMedCrossRefGoogle Scholar
  12. 12.
    H. Porschke, H. Strenge, and C. Stauch, Polyneuropathy and central nervous system before and after heart transplantation. Is cyclosporin neurotoxic? Dtsch. Med. Wochenschr. 116(42), 1577–1582 (1991).PubMedCrossRefGoogle Scholar
  13. 13.
    T. Kishimoto, T. Tsujino, T. Nakatani, T. Kim, A. Ohyama, W. Sakamoto, et al., Effect of cyclosporin on cardiac output and regional blood flow in rats: cyclosporin-induced nephropathy and its prevention with calcium channel blocker, Nephron 61(2), 204–210 (1992).PubMedGoogle Scholar
  14. 14.
    N. Wellinghausen, H. Kirchner, and L. Rink, The immunobiology of zinc, Immunol. Today 18(11), 519–521 (1997).PubMedCrossRefGoogle Scholar
  15. 15.
    K. H. Neldner and K. M. Hambidge, Zinc therapy of acrodermatitis enteropathica, N. Engl. J. Med. 292, 879–882 (1975).PubMedCrossRefGoogle Scholar
  16. 16.
    N. Wellinghausen and L. Rink, The significance of zinc for leukocyte biology, J. Leukocyte Biol. 64, 571–577 (1998).PubMedGoogle Scholar
  17. 17.
    C. Driessen, K. Hirv, H. Kirchner, and L. Rink, Zinc regulates cytokine induction by superantigens and lipopolysaccharids, Immunology 84, 272–277 (1995).PubMedGoogle Scholar
  18. 18.
    S. G. Danzer, H. Kirchner, and L. Rink,. Cytokine interactions in human mixed lymphocyte culture, Transplantation 57, 1638–1642 (1994).PubMedGoogle Scholar
  19. 19.
    S. Landolfo, F. Cofano, M. Giovarelli, M. Prat, G. Cavallo, and G. Forni, Inhibition of interferon-gamma may supress allograft reactivity by T lymphocytes in vitro and in vivo, Science 229, 176–179 (1985).PubMedCrossRefGoogle Scholar
  20. 20.
    R. H. Didlake, E. K. Kim, K. Sheehan, R. D. Schreiber, and B. D. Kahan, Effect of combined anti-gamma interferon antibody and cyclosporine therapy on cardiac allograft survival in the rat, Transplantation 45, 222–223 (1988).PubMedCrossRefGoogle Scholar
  21. 21.
    J. C. Carel, R. D. Schreiber, L. Falqui, and P. E. Lacy, Transforming growth factor beta decreases the immuogenicity of rat islet xenografts (rat to mouse) and prevents rejection in association with treatment of the recipient with a monoclonal antibody to interferon gamma, Proc. Natl. Acad. Sci. (USA) 87, 1591–1595 (1990).CrossRefGoogle Scholar
  22. 22.
    A. S. Rosenberg, D. S. Finbloom, T. G. Maniero, P. H. Van der Meide, and A. Singer, Specific prolongation of the MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody, J. Immunol. 144, 4648–4650 (1990).PubMedGoogle Scholar
  23. 23.
    N. Boukaiba, C. Flament, S. Archer, P. Chappuis, A. Piau, M. Fusselier, et al., A physiological amount of zinc supplementation: effect on nutritional, lipid and thymic status in an elderly population, Am. J. Clin. Nutr. 57, 566–572 (1993).PubMedGoogle Scholar
  24. 24.
    N. Wellinghausen, M. Martin, and L. Rink, Zinc inhibits interleukin-1-dependent T cell stimulation, Eur. J. Immunol. 27, 2529–2535 (1997).PubMedCrossRefGoogle Scholar
  25. 25.
    C. Driessen, K. Hirv, L. Rink, and H. Kirchner, Induction of cytokines by zinc ions in human pripheral blood mononuclear cells and separated monocytes, Lymphokine Cytokine Res. 13(5), 15–20 (1994).PubMedGoogle Scholar
  26. 26.
    K. Gagne, S. Brouard, M. Giral, F. Sebille, A. Moreau, M. Guillet, et al., Highly altered Vβ repertoire of T cells infiltrating long-term rejected kidney allografts, J. Immunol. 164, 1553–1563 (2000).PubMedGoogle Scholar
  27. 27.
    J. D. Fraser, R. G. Urban, J. L. Strominger, and H. Robinson, Zinc regulates the function of two superantigens, Proc. Natl. Acad. Sci. (USA) 89(12), 5507–5511 (1992).CrossRefGoogle Scholar
  28. 28.
    A. Favier and M. Favier, Consequences des deficits en zinc durant la grossesse pour la mere et le nouveau-ne, Rev. Fr. Gynecol. Obstet. 85, 13–27 (1990).PubMedGoogle Scholar
  29. 29.
    A. E. Favier, The role of zinc in reproduction. Hormonal mechanisms, Biol. Trace Element Res. 32, 363–382 (1992).Google Scholar

Copyright information

© Humana Press Inc 2001

Authors and Affiliations

  • Cathrin A Campo
    • 1
  • Nele Wellinghausen
    • 2
  • Christian Faber
    • 1
  • Andrea Fischer
    • 1
  • Lothar Rink
    • 1
  1. 1.Institute of Immunology and Transfusion MedicineUniversity of Lübeck School of MedicineLübeckGermany
  2. 2.Section of Infectious Diseases and Clinical ImmunologyUniversity of UlmUlmGermany

Personalised recommendations